St. Charles Health System - Behavioral Health Consultant Project

The Behavioral Health Consultant (BHC) project embeds psychologists trained in integrated primary care directly into clinics throughout the region. These providers work with the primary care provider to address mental and emotional issues that can affect a patient's ability to comply with their health care plan.

What is it?

The Behavioral Health Consultant (BHC) project embeds psychologists trained in integrated primary care directly into clinics throughout the region. These providers work with the primary care provider to address mental and emotional issues that can affect a patient's ability to comply with their health care plan.

Who is it for?

High-risk, high-needs patients with one or more chronic health issues (chronic pain, diabetes, etc.).

Why do they do it?

As part of the care team for the primary health conditions, BHC providers are changing the way clinics provide care overall.

Impact

Approximately 3,500 patients have been served within the past 24 months. Working with regional emergency departments (EDs), these providers helped reduce ED usage in high-utilizing populations by more than 50 percent in one year.

Contact: Robin Henderson, PsyD
Director, Behavioral Health Services
Acting Executive Director, Central Oregon Health Council
Telephone: 541-706-2791
E-mail: rhenderson@stcharleshealthcare.org

Related Resources

Letter
Public
AHA letter to Representatives Greg Walden, and Frank Pallone expressing support for The Limited Repeal of the IMD Exclusion for Adult Medicaid Beneficiaries…
Press Releases
Public
Tom Nickels Executive Vice President American Hospital Association
Testimony
Public
AHA expresses strong support for legislation that would allow responsible sharing of patient substance use disorder (SU
Webinar Recordings
Monday, December 15, 2014 On behalf of the American Hospital Association (AHA) Sections for Maternal and Child Health and Psychiatric and
Letter
The undersigned groups thank the Drug Enforcement Administration (DEA) for the opportunity to comment on its proposed rule regarding controlled sub
Letter
We concur with the DEA that setting quotas for the production of opioid medications can be an effective step in “preventing the accumulation of con